132 filings
Page 6 of 7
424B3
gv7bgwj0
25 Nov 20
Prospectus supplement
11:12am
6-K
ef4t1a2
25 Nov 20
PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer
10:08am
6-K
8s38jx4cioaq6a71qcd3
13 Nov 20
Report of Foreign Private Issuer
6:09am
6-K
vbv s7koi5
9 Nov 20
PainReform Welcomes Senior Pharmaceutical Executive and Venture Capitalist Augustine Lawlor to Board of Directors
10:30am
6-K
6jx 0a34x9i2frq
19 Oct 20
PainReform Highlights Surgical Advantages of PRF-110
1:37pm
424B3
nyz26qvia2g9 tloa
30 Sep 20
Prospectus supplement
4:42pm
6-K
efck8whhe7v 19zf
30 Sep 20
Condensed Financial Statements
4:32pm
424B4
komlmtmnqi
2 Sep 20
Prospectus supplement with pricing info
4:09pm
EFFECT
d0z4w19 uf5gu
1 Sep 20
Notice of effectiveness
12:15am
CERT
r2ku5xw9u8pfdp1p7x4z
31 Aug 20
Certification of approval for exchange listing
4:56pm
8-A12B
dekmdte9l2koq
31 Aug 20
Registration of securities on exchange
6:08am
F-1/A
rkmrv6ra gxs4865x
31 Aug 20
Registration statement (foreign) (amended)
6:06am
CORRESP
70u8gm8zzlj8ed
27 Aug 20
Correspondence with SEC
12:00am
CORRESP
4gi832 d4zzlqldx5lt
27 Aug 20
Correspondence with SEC
12:00am
F-1/A
u2skltohf xy
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
yagl6kur1ursllh8yy2
10 Aug 20
Registration statement (foreign) (amended)
4:15pm
UPLOAD
opwvjqe 627
10 Aug 20
Letter from SEC
12:00am
CORRESP
tzbpdzx8l7 xf5m
10 Aug 20
Correspondence with SEC
12:00am
F-1/A
fyi7 zor6fw8q43m53
5 Aug 20
Registration statement (foreign) (amended)
1:26pm
CORRESP
ei5jt7
5 Aug 20
Correspondence with SEC
12:00am